Czech CLL Study Group
Quick facts
Phase 2 pipeline
- Bendamustine and Rituximab · Oncology
Bendamustine is a chemotherapy medication that interferes with DNA replication, while Rituximab is a monoclonal antibody that targets and depletes B cells.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: